Puma Biotechnology (PBYI) Profit After Tax (QoQ) (2011 - 2026)
Puma Biotechnology (PBYI) Profit After Tax (QoQ) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | Puma Biotechnology | 409.56 Mn | 371.27 Mn | 34.39 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -127.93% |
| Dec 31, 2025 | 51.94% |
| Sep 30, 2025 | 51.05% |
| Jun 30, 2025 | 96.87% |
| Mar 31, 2025 | -84.59% |
| Dec 31, 2024 | -4.98% |
| Sep 30, 2024 | 548.60% |
| Jun 30, 2024 | 5.94% |
| Mar 31, 2024 | -139.25% |
| Dec 31, 2023 | 111.66% |
| Sep 30, 2023 | 172.62% |
| Jun 30, 2023 | 51.75% |
| Mar 31, 2023 | 124.99% |
| Dec 31, 2022 | -1,457.22% |
| Sep 30, 2022 | -103.84% |
| Jun 30, 2022 | 375.37% |
| Mar 31, 2022 | -180.56% |
| Dec 31, 2021 | 109.46% |
| Sep 30, 2021 | -774.89% |
| Jun 30, 2021 | -130.89% |